» Download Public Reports
38 reports
- Company report
- October 2012
- 216 pages
- by Corporation
... Most advanced therapeutic cands are in clinical development. We, or our licensees, as applicable, will be required to conduct significant additional clinical trials before we or they can seek ...
September 2012
... Production as necessary; The risk that the data collected from our current and planned clinical trials may not be sufficient to demonstrate that the mguard Technology is an attractive alternative to other ...
September 2012
... Most advanced therapeutic cands are in clinical development. We, or our licensees, as applicable, will be required to conduct significant additional clinical trials before we or they can seek ...
December 2012
... Improvement in all parameters with a similar safety profile as seen in the phase iii clinical trial. In the phase iii clinical trial, the 60 u/kg group demonstrated a statistically significant mean reduction ...
December 2012
... Therapeutic cand development efforts, as well as the extent and number of additional studies that we may be required to conduct; Our ability to advance our therapeutic cands into clinical trials ...
February 2013
... And at least one additional ingredient. Contemplated clinical trial Shall mean one of the two non-comparative clinical trials managed by licensor as of the execution date, studying the effects of the drug ...
February 2013
... Unforeseen events during, or as a result of, the clinical trial process that could delay or prevent commercialization of our current or future therapeutic cands, including but not limited to ...
December 2012
... And 27 months in the extension trial), patients continued to demonstrate a significant improvement in all parameters with a similar safety profile as seen in the phase iii clinical trial. In the phase ...
December 2012
... The initiation, timing, progress and results of our preclinical studies, clinical trials, and other therapeutic cand development efforts, as well as the extent and number of additional studies that we may ...
May 2012
... Healthy adults Checks safety phase ii In patients Usually tens of people phase iii Main clinical trial Efficacy vs. Placebo time table for drug development pre - clinical trials phase Figuring proper ...